Pfizer Inc.
PFE
Classifica tra le azioni
#119
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Prezzo delle azioni
$29.47
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$167.94B
Variazione (1 giorno)
-0.27%
Variazione (1 anno)
19.34%
Paese
US
Scambia Pfizer Inc. (PFE)
Categoria
Healthcare
Numero di azioni in circolazione per Pfizer Inc. (PFE)
Numero di azioni in circolazione al June 2026: 5.70B
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Pfizer Inc., il numero attuale di azioni in circolazione è 5.70B. Alla fine del December 2024, la società aveva 5.66B azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Pfizer Inc. (PFE) dal 2000 al 2026
Azioni in circolazione alla fine di ogni anno
| Anno | Azioni in circolazione | Cambia |
|---|---|---|
| 2026 (TTM) | 5.70B | 0.29% |
| 2025 | 5.68B | 0.33% |
| 2024 | 5.66B | 0.37% |
| 2023 | 5.64B | 0.62% |
| 2022 | 5.61B | 0.12% |
| 2021 | 5.60B | 0.83% |
| 2020 | 5.56B | -0.25% |
| 2019 | 5.57B | -5.16% |
| 2018 | 5.87B | -1.64% |
| 2017 | 5.97B | -1.95% |
| 2016 | 6.09B | -1.41% |
| 2015 | 6.18B | -2.68% |
| 2014 | 6.35B | -6.85% |
| 2013 | 6.81B | -8.45% |
| 2012 | 7.44B | -4.80% |
| 2011 | 7.82B | -2.73% |
| 2010 | 8.04B | 14.69% |
| 2009 | 7.01B | 4.16% |
| 2008 | 6.73B | -2.75% |
| 2007 | 6.92B | -4.49% |
| 2006 | 7.24B | -1.62% |
| 2005 | 7.36B | -2.26% |
| 2004 | 7.53B | 4.41% |
| 2003 | 7.21B | 17.17% |
| 2002 | 6.16B | -1.33% |
| 2001 | 6.24B | 0.47% |
| 2000 | 6.21B | 0.00% |
Azioni in circolazione per aziende simili o concorrenti
| Azienda | Azioni in circolazione | Differenza | Il paese |
|---|---|---|---|
| 892.40M | -84.34% |
US
|
|
| 2.45B | -57.05% |
US
|
|
| 1.77B | -68.92% |
US
|
|
| 0.00 | -100.00% |
US
|
|
| 796.00M | -86.03% |
CH
|
